Novo Nordisk A/S
CSE:NOVO B
Novo Nordisk A/S
CSE:NOVO B
Price:
850.6 DKK
-2.58%
Market Closed
Updated:
May 5, 2024
Novo Nordisk A/S
Other Operating Expenses
|
Novo Nordisk A/S
Other Operating Expenses Peer Comparison
Comparables:
HLUN A
ALK B
Competitive Other Operating Expenses Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Other Operating Expenses | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Novo Nordisk A/S
CSE:NOVO B
|
Other Operating Expenses
kr681m
|
CAGR 3-Years
5%
|
CAGR 5-Years
-15%
|
CAGR 10-Years
0%
|
|
|
H Lundbeck A/S
CSE:HLUN A
|
Other Operating Expenses
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
ALK-Abello A/S
CSE:ALK B
|
Other Operating Expenses
kr2m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
-41%
|
CAGR 10-Years
N/A
|
See Also
What is Novo Nordisk A/S's Other Operating Expenses?
Other Operating Expenses
681m
DKK
681m
DKK
Based on the financial report for Dec 31, 2023, Novo Nordisk A/S's Other Operating Expenses amounts to 681m DKK.
What is Novo Nordisk A/S's Other Operating Expenses growth rate?
Other Operating Expenses CAGR 10Y
0%
0%
Over the last year, the Other Operating Expenses growth was -49%. The average annual Other Operating Expenses growth rates for Novo Nordisk A/S have been 5% over the past three years , -15% over the past five years .
You don't have any saved screeners yet
